Mastercard Incorporated (BCBA:MA)

Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions ARS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	689,187,599	498,284,655	323,369,247	59,217,585	36,255,317	29,922,799
Market Cap Growth	62.58%	54.09%	446.07%	63.33%	21.16%	65.90%
Enterprise Value	701,883,580	505,325,354	329,584,048	60,313,982	36,928,764	30,093,838
Last Close Price	23050.00	19009.45	12476.22	3585.05	2187.83	-
PE Ratio	42.57	37.54	35.73	33.67	40.64	55.51
PS Ratio	19.12	17.16	15.94	15.04	18.70	23.26
PB Ratio	73.45	74.18	57.16	52.43	47.63	54.60
P/FCF Ratio	-	33.78	34.45	31.09	38.99	51.68
P/OCF Ratio	-	32.70	33.39	29.86	37.31	49.26
EV/Sales Ratio	17.59	17.40	16.24	15.31	19.04	23.39
EV/EBITDA Ratio	28.34	28.25	26.56	25.34	32.71	40.94
EV/EBIT Ratio	29.96	29.79	28.02	26.84	35.02	43.85
EV/FCF Ratio	35.58	34.26	35.12	31.67	39.71	51.98
Debt / Equity Ratio	2.41	2.91	2.35	2.32	1.98	2.08
Debt / EBITDA Ratio	1.01	1.09	1.07	1.10	1.33	1.55
Debt / FCF Ratio	1.15	1.33	1.42	1.38	1.62	1.96
Asset Turnover	0.65	0.62	0.62	0.58	0.53	0.49
Quick Ratio	0.71	0.65	0.81	0.76	0.83	1.12
Current Ratio	1.16	1.03	1.17	1.17	1.29	1.61
Return on Equity (ROE)	176.95%	190.56%	167.41%	144.03%	124.73%	102.51%
Return on Assets (ROA)	23.68%	22.72%	22.40%	20.76%	18.01%	16.24%
Return on Capital (ROIC)	44.46%	42.01%	40.75%	36.66%	30.47%	28.89%
Return on Capital Employed (ROCE)	54.80%	57.00%	55.60%	51.70%	41.90%	37.50%
Earnings Yield	2.35%	2.66%	2.80%	2.97%	2.46%	1.80%
FCF Yield	2.86%	2.96%	2.90%	3.22%	2.56%	1.93%
Dividend Yield	0.30%	14.86%	15.36%	10.08%	8.50%	-
Payout Ratio	19.15%	19.02%	19.28%	19.16%	20.04%	25.04%
Buyback Yield / Dilution	2.19%	2.01%	2.57%	2.12%	1.39%	1.57%
Total Shareholder Return	2.49%	16.87%	17.93%	12.20%	9.89%	1.57%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.